High-performance liquid chromatography (HPLC) is the method behind most purity figures on peptide certificates of analysis. When a report says “Purity: 98.7% (HPLC),” it is summarizing a chromatogram. Understanding how that chromatogram is produced, and what it can miss, makes it much easier to judge what the number actually means.
This article explains HPLC for peptides in plain terms. It does not cover laboratory procedures in operational detail; the goal is to help readers interpret HPLC results, not to run the analysis.
What HPLC Does
HPLC separates the components of a dissolved sample so they can be detected one at a time. The sample is carried by a liquid (the mobile phase) through a tightly packed column (the stationary phase). Different molecules interact with the column to different degrees, so they travel through it at different speeds and exit at different times.
A detector at the end of the column records a signal as each component exits. The result is a chromatogram: a graph of detector response over time, in which each separated component ideally appears as its own peak.
How Peptides Are Typically Analyzed
Reversed-phase separation
Peptide purity is most commonly assessed with reversed-phase HPLC (RP-HPLC). In this mode, the column surface is hydrophobic (C18 columns are a common choice), and the mobile phase is a mixture of water and an organic solvent such as acetonitrile. Molecules are separated largely according to their hydrophobicity: more hydrophobic molecules interact more strongly with the column and elute later.
Gradient elution
Peptide methods usually use a gradient, gradually increasing the proportion of organic solvent over the run. This helps elute molecules across a range of hydrophobicities and sharpens peaks. An additive, often trifluoroacetic acid (TFA) or formic acid, is commonly included to improve peak shape. Formic acid is often preferred when the method is coupled to mass spectrometry, because TFA can suppress the MS signal.
UV detection
The most common detector is ultraviolet (UV) absorbance. The peptide bond absorbs in the low-UV region, so peptide methods frequently monitor around 214 to 220 nanometers. Some methods also monitor around 280 nanometers, where aromatic amino acids such as tryptophan and tyrosine absorb.
Reading a Chromatogram
A chromatogram contains more information than the single purity figure it usually produces. When one is provided, look for:
- Axis labels: time (usually minutes) on the horizontal axis and detector response (often milli-absorbance units, mAU) on the vertical axis.
- Retention time: when the main peak exits the column. Retention time is method-specific, so it is meaningful mainly when compared with a reference standard run under the same conditions.
- Peak shape: a sharp, symmetrical main peak is generally easier to integrate accurately. Shoulders, tailing, or a broad hump may indicate unresolved components or method issues.
- Minor peaks: small peaks before and after the main peak usually represent impurities or other components.
- Peak table: a list of each integrated peak with its retention time, area, and area percentage.
How the Purity Figure Is Calculated
Most peptide purity values are area-percent values. The software integrates the area under every peak above a set threshold, then reports the main peak’s area as a percentage of the total. If the main peak accounts for 987 of 1,000 total area units, the reported purity is 98.7%.
This calculation is simple, which is part of its appeal. It also explains its limits.
What HPLC Purity Does Not Tell You
It is relative, not absolute
Area percent is a proportion of what the detector recorded. It is not a percentage by weight of the vial’s contents. Water, salts, and counter-ions such as trifluoroacetate do not appear as peptide peaks in a typical UV chromatogram, so a high area-percent purity can coexist with a peptide content well below the labeled amount.
It assumes similar detector response
Area percent treats each unit of area as equivalent. In reality, different molecules absorb UV light to different degrees. Impurities closely related to the target peptide often respond similarly at low-UV wavelengths, but this is an approximation, not a guarantee.
It can only count what it separates and detects
If an impurity co-elutes with the main peak, it is counted as part of the main peak, inflating apparent purity. Impurities that do not absorb at the monitored wavelength, or that are retained on the column or elute outside the integration window, are not counted at all. Integration settings, such as the threshold below which small peaks are ignored, also affect the result.
It does not establish identity
A single dominant peak shows that most of the detected material behaves as one component under that method. It does not show which compound that component is. Identity requires separate evidence, typically mass spectrometry or comparison with an authenticated reference standard.
Method Quality and Validation
Two laboratories can analyze the same sample and report different purity values if their methods differ in column, gradient, wavelength, or integration settings. This is why a method’s suitability matters.
In regulated pharmaceutical settings, analytical procedures are expected to be validated for characteristics such as specificity, accuracy, precision, linearity, and range. The internationally harmonized guideline on this subject is ICH Q2(R2), available through the FDA as Q2(R2) Validation of Analytical Procedures. Research-market testing is not necessarily performed to this standard, but the guideline is a useful reference for what a well-characterized method is expected to demonstrate.
On a certificate of analysis, signs of a better-documented method include a stated column type, mobile phases, gradient or run time, detection wavelength, and reference to a reference standard where one was used.
HPLC Combined With Mass Spectrometry
Liquid chromatography can be coupled directly to a mass spectrometer (LC-MS). The chromatography separates components; the mass spectrometer measures mass-to-charge ratios for what elutes. This combination can support the identity of the main peak and help characterize impurity peaks, including some that would not be distinguished by UV alone. Tandem mass spectrometry (LC-MS/MS) adds fragmentation data that can provide sequence-level information.
For a broader discussion of why multiple methods provide stronger evidence, see the role of independent purity testing. For how HPLC results appear on an actual report, see how to read third-party lab results.
Questions to Ask About an HPLC Result
- Is a chromatogram provided, with labeled axes and a peak table?
- Does the main peak’s area percentage match the reported purity?
- Are the column, mobile phase, and detection wavelength stated?
- Was a reference standard used?
- Is identity supported by a separate method?
- Does the report address peptide content or quantity, or only purity?
Key Takeaways
- HPLC separates components; the purity figure is usually the main peak’s share of total peak area.
- Area-percent purity is relative to what the detector sees and is not a weight-based content figure.
- Co-eluting or undetected impurities can make purity appear higher than it is.
- HPLC alone does not establish identity; mass spectrometry or a reference standard is needed.
- Method details and validation affect how much weight a purity figure deserves.
Disclaimer: This article is an educational overview of an analytical method and does not assess any product. It is not laboratory, medical, or purchasing advice.
Our vendor reviews read HPLC results this way. For example, the Nova Life Peptides review covers reports that pair HPLC purity with mass-spectrometry identity, and the MyPurePeptide review shows why the measured amount matters as much as the purity figure.